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Jubi Formula® is a herbal preparation made from three medicinal herbs (Parquetina nigrescens, 
Sorghum bicolor and Harungana madagascariensis).  It has been reported to have been successfully 
used in the treatment of anaemia in humans. A study was therefore carried out to determine the effect 
of the preparation on packed cell volume (PCV) and haemoglobin (Hb) concentrations in anaemic 
rabbits. The PCV and Hb concentrations of healthy rabbits infected with Trypanosoma brucei brucei 
were monitored for 49 days. T. b. brucei produced a significant reduction in PCV and Hb 
concentrations in all infected rabbits when compared with the controls (p<0.05). These hematological 
parameters were restored to normal levels in the anaemic rabbits by the herbal preparation. The 
anaemic rabbits not treated with the herbal preparation presented with a progressive decline in their 
PCV and Hb concentrations and majority of them died before the end of the study.  Healthy rabbits 
that received daily doses of the herbal preparation showed gradual elevation in PCV and Hb 
concentrations which were maintained within normal range. Jubi Formula® can restore the PCV and 
Hb concentrations in anaemic conditions and is a potential substitute for blood transfusion. However, 
further studies are needed to investigate the potentials of the herbal preparation in reversing 
anaemia. 
 





Over the years, medicinal plants have been recognised to 
be of great importance to the health of individuals and 
communities. In many developing countries, herbal 
medicines are assuming greater importance in primary 
health care and their international trade has increased. 
However, the markets in these countries are not 
adequately regulated and many herbal products in 
circulation are unregistered by national regulatory bodies 
(WHO, 1996).  
Jubi Formula, manufactured by Health Forever 
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preparation that recently made its way into the herbal 
medicine market in Nigeria. It is available as a powdered 
preparation formulated into capsules and suspension and 
contains iron, protein, fat, carbohydrates, tannins, 
saponins, and coumarins. The product was made from 
three medicinal herbs (Parquetina nigrescens, Sorghum 
bicolor and Harungana madagascariensis). Parquetina 
nigrescens (family: Periplocaceae) is a shrub found in 
equatorial West Africa (Irvine, 1961; Mabberley, 1987) 
while Sorghum bicolor or Sorghum (family: Gramineae) is 
an important staple food crop in Africa, South Asia, and 
Central America, and is also grown in some developed 
nations for animal feed (ICRISAT, 1993). Harungana 
madascariensis (family: Clusiaceae) is a native of 
Madagascar, Mauritius and tropical Africa (Hutchinson, 
and Dalziel, 1954).  




The product is believed to elevate packed cell volume 
(PCV) and is recommended by the manufacturer for the 
support of treatment of moderate to severe anaemia as in 
sickle cell anaemia, cancer and HIV/AIDS. It is also said 
to be suitable as a nutritional supplement in stress, 
exhaustion and convalescent situations as well as helpful 
in diabetes, hypertension, arthritis and infertility. The sap 
of H. madagascariensis has been used in the treatment 
of skin diseases, leprosy spots and wounds while the 
leaves of P. nigrescens has been used for wounds in 
Africa (Irvine, 1961; Mabberley, 1987), and has 
sympathomimetic effects (Datté et al., 1999). However, 
no scientific data has been published to show the 
combined effects of the components of Jubi Formula on 
PCV and Hb concentrations in mammals.  
The main objective of this study was to investigate the 
claim by the manufacturer that the product increases 
packed cell volume (PCV) in anaemia. The specific 
objective is to determine the effect of the herbal 
preparation on PCV and haemoglobin concentrations in 
rabbits with parasitemia-induced anaemia. 
 
 
MATERIALS AND METHODS 
 
Thirty-six locally bred rabbits – average weight, 1.181.73 kg; 
weight range, 0.94 – 1.46 kg purchased in Benin City were kept in 
standard rabbit cages (which were regularly cleaned and 
disinfected using standard procedures). The cages were located in 
the animal house in the Department of Pharmacology & Toxicology, 
University of Benin, Benin City, Nigeria. The rabbits were allowed 
unrestricted access to normal rabbit chow (Bendel Feed and Flower 
Mills Ltd., Ewu, Edo State, Nigeria) and water, and allowed to 
acclimatize to their new environment for four weeks. During the 
acclimatization period, the animals were treated with terramycin 
(200 mg/kg) (May and Baker Ltd., England) in the first week (to 
exclude bacteria infections) and blood samples were collected on 
microscope slides from each animal through the auricular vein 
every week, and examined under a microscope for presence of 
parasites (World Organisation for Animal Health, 2000) and 
bacteria. Six animals with blood infections were excluded from the 
experiment.  
The thirty healthy rabbits were divided into five equal groups 
(groups A – E). Rabbits in groups A and B were used as controls; 
weekly blood monitoring indicated the absence of parasites and 
bacteria in their blood samples. The animals in groups C, D and E 
were infected with Trypanosoma brucei brucei Federe Plateau (T. 
b. brucei) and the presence of the parasite in blood was monitored 
daily through the auricular vein until parasitemia was established, 
usually within 5 – 10 days post-infection. Each animal in groups B, 
C and D received 3.4 ml/kg of aqueous suspension of Jubi 
Formula powder (1 mg/60ml) orally every day from day 1, the day 
they were infected with T. b. brucei and the day parasitemia was 
established, respectively. Parasitemia in the rabbits in groups C, D 
and E were induced by mouse inoculation technique (World 
Organisation for Animal Health, 2000) using a single dose of 0.25 
ml of T. b. brucei-infected blood of albino rat. The blood samples 
were diluted (50:50) with normal saline before injecting 
intraperitoneally into the rabbits. The infected albino rats were 
obtained from the National Institute for Trypanosomiasis Research 
(NITR), Vom, Plateau State, Nigeria. 
Uncoagulated blood samples of the rabbits were obtained every 
week from the animals. The samples were collected in 5 ml EDTA 





determined within 24 h of collection using the microhaematocrit and 
cyanomethaemoglobin methods (Omotainse and Anosa, 1992; 
Schalm et al., 1975), respectively. The proportional changes in PCV 
and Hb concentrations of the rabbits were determined as follows: 
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HH  100*    … ..(2) 
 
where Pt and P0 are the PCV at time, t and day 1, respectively and 
Ht and Ho are the Hb concentrations at time, t and day 1, 
respectively. The differences in these hematological parameters 
were analysed statistically using one-way analysis of variance 
(ANOVA) with Instat® software (GraphPad Inc., USA). Statistical 
estimates were made at confidence interval of 95% and probability 
values of ≤0.05 were considered significant.  
The ethical approval for this study was obtained from the 
Department of Pharmacology and Toxicology, University of Benin, 





The changes in packed cell volume (PCV) and 
haemoglobin (Hb) concentrations of the rabbits during the 
period of the study are presented in Tables 1 and 2, 
respectively. The control rabbits had PCV and Hb 
concentrations within the normal range throughout the 
duration of the experiment (PCV: mean, 37.0±2.8%; 
median, 37%; 95% confidence limit, 36.1 - 39.9%; Hb: 
mean, 11.45±1.18 g/dl; median, 11.73 g/dl; 95% 
confidence limit, 11.115 – 13.575 g/dl). The rabbits in 
group B had slightly higher (but not significantly different, 
p > 0.05) PCV and Hb concentrations from the third week 
of treatment with the herbal preparation than those in 
group A. Groups A and B animals had PCV and Hb 
concentrations within the normal range. As much as 
17.2±2.0% elevation in PCV and 15.0±13.0% elevation in 
Hb concentrations were achieved in the group B rabbits 
treated with Jubi Formula® within six weeks. The PCV 
and Hb concentrations were maintained within normal 
range by the Jubi Formula®. The PCV and Hb 
concentrations of animals in groups C, D and E were 
significantly lower than those of the animals in groups A 
and B (p<0.05). During the course of the experiment (49 
days), the PCV of the parasite-infected rabbits not treated 
with Jubi Formula® (Group E) progressively fell to as low 
as 25% and five of the rabbits died before the end of the 
experiment; one dying on the 15th day and the others 
dying between the 30th and 48th days. The parasite 
infected rabbits treated with Jubi Formula® from day 1 
gradually developed lower PCV and Hb concentrations, 
with PCV values of 27% recorded in one rabbit and 28% 
recorded in three other rabbits. However, the PCV and 
Hb concentrations of these animals increased 
progressively from the fifth week  of  treatment  to  normal  




Table 1. Packed cell volume (l/l) of healthy (groups A and B) and T. b. brucei infected rabbits (groups C – E) either treated 
(groups B – D) or untreated (groups A and E) with Jubi Formula. 
 
Packed cell volume (l/l) of rabbits (mean±sd)  
Day 
Group Aa Group Bb Group Cc Group Dd Group Ee 
-14 0.360±0.05 0.363±0.03 0.370±0.04 0.383±0.03 0.375±0.03 
-7 0.365±0.04 0.365±0.04 0.358±0.02 0.368±0.02 0.368±0.02 
1 0.375±0.03 0.348±0.02 0.350±0.02 0.370±0.01 0.378±0.03 
7 0.365±0.02 0.378±0.02 0.360±0.02 0.358±0.03 0.350±0.02 
14 0.363±0.02 0.365±0.01 0.338±0.01 0.345±0.03 0.318±0.02 
21 0.368±0.03 0.375±0.02 0.308±0.02 0.313±0.01 0.295±0.02 
28 0.375±0.03 0.390±0.01 0.300±0.03 0.295±0.02 0.268±0.02 
35 0.385±0.02 0.403±0.04 0.305±0.02 0.288±0.03 0.260±0.01 
42 0.365±0.02 0.408±0.05 0.325±0.01 0.315±0.03 0.255±0.01 
49 0.383±0.04 0.403±0.02 0.323±0.03 0.323±0.02 0.253±0.01 
 
a,cp<0.05; a,dp<0.05; a,ep<0.001; b,cp<0.05; b,dp<0.01; b,ep<0.001Group A, healthy rabbits, controls, no Jubi Formula® administered; 
Group B, healthy rabbits, Jubi Formula® administered from day 1 – 49; Group C, rabbits infected  with T. b. brucei and Jubi 
Formula® administered from days 1 - 49; Group D, rabbits infected  with T. b. brucei and Jubi Formula® administered from day 10 - 






Table 2. Haemoglobin concentrations (g/dl) of healthy (groups A and B) and T. b. brucei infected rabbits (groups C – E) 
either treated (groups B – D) or untreated (groups A and E) with Jubi Formula. 
 
Packed cell volume (l/l) of rabbits (mean±sd)  
Day 
Group Aa Group Bb Group Cc Group Dd Group Ee 
-14 11.50±0.91 11.38±1.11 11.50±1.08 11.7±1.19 12.13±1.18 
-7 12.08±0.98 11.75±0.87 11.37±1.14 11.88±0.63 12.50±0.82 
1 12.50±0.71 11.80±0.36 12.00±0.41 12.25±0.65 12.95±0.84 
7 12.05±0.90 12.55±0.42 11.63±0.85 11.63±1.49 11.70±0.81 
14 12.03±0.92 12.08±0.51 11.25±0.65 11.75±0.87 10.63±0.85 
21 12.13±1.11 12.43±0.85 10.25±0.65 10.75±0.29 10.25±1.44 
28 11.88±0.25 12.78±0.26 10.2±0.81 10.00±0.71 9.13±0.48 
35 12.28±1.44 13.13±1.49 10.38±0.63 9.88±0.75 9.00±0.71 
42 11.78±0.63 13.58±1.65 11.13±0.75 11.00±0.41 8.63±0.48 
49 12.61±1.14 13.23±0.89 10.25±0.50 10.88±0.85 8.38±0.25 
 
a,cp<0.05; a,dp<0.05; a,ep<0.01; b,cp<0.01; b,dp<0.05; b,ep<0.001Group A, healthy rabbits, controls, no Jubi Formula® administered; 
Group B, healthy rabbits, Jubi Formula® administered from day 1 – 49; Group C, rabbits infected  with T. b. brucei and Jubi 
Formula® administered from days 1 - 49;Group D, rabbits infected  with T. b. brucei and Jubi Formula® administered from day 10 - 




levels. Similarly, the parasite-infected rabbits that were 
treated with Jubi Formula® from the 10th day 
progressively developed lower PCV and Hb 
concentrations, with a PCV value of 26% recorded in one 
of the rabbits. There were significantly lower PCV and Hb 
concentrations in the animals in Group D than those in 
Group C (p<0.05). Like the rabbits in Group C, the rabbits 
in Group D had PCV and Hb concentrations which 
increased gradually from the fifth week of treatment to 
normal  levels.   The   PCV   and   Hb   concentrations   of  




animals in Group E fell significantly below the normal 
levels. Proportional changes in PCV and Hb 
concentrations of the rabbits during the course of the 
experiment (as calculated in equations 1 and 2) are 
shown in Figures 1 and 2. The maximum reductions in 
PCV and Hb concentrations in the untreated rabbits 
infected with T. b. brucei in this study were 32.8±5.8% 
and 35.2±3.0%, respectively.  
 
Figure 1. Proportional change in PCV levels of healthy and T. b. 




Figure 2. Proportional change in Haemoglobin concentrations of 
healthy and T. b. brucei-infected rabbits either treated or untreated 




Microscopic examination of the rabbit blood revealed 
macrocytic normochromic anemia within three weeks 
post-infection with the T. b. brucei. Microcytes and 
hypochromia were evident from the third week of 






anaemia later changed to microcytic hypochromic 
anaemia in the infected rabbits. The infected rabbits also 
showed evidence of polychromia from the third week 
post-infection but this was not sustained in the rabbits 
treated with Jubi Formula. Moderate nucleated red cells, 
which were also present in the control groups (group A 
and B) throughout the study period, declined in the 
parasitemia rabbits (groups C – E) from the third week 
post-infection. There were no noticeable abnormalities in 





Trypanosoma brucei brucei is a tissue parasite which 
induces anaemia in infected rabbits, as in other 
susceptible animals such as cattle, dogs, rats, mice 
(Jenkins et al., 1980; McCrorie et al., 1980). As reported 
previously (Jenkins et al., 1980; Mwangi et al., 1995), T. 
b. brucei successfully produced anaemia in all infected 
rabbits resulting in the significant reduction in PCV and 
haemoglobin (Hb) concentrations. The maximum 
reduction in the PCV and Hb concentrations were, 
however, not as low as the 50% that has been reported 
to be possible. Occurrence of parasitemia within 5 to 10 
days post-inoculation with T. b. brucei is in line with the 
parasite’s known incubation period of 5 to 10 days (Maré, 
2000). The PCV and Hb concentrations of healthy rabbits 
treated with Jubi Formula® did not exceed normal levels 
and no abnormalities in the red blood cells of the animals 
were observed suggesting that the herbal preparation 
can be used in healthy rabbits without hematological 
disorder. Nucleated red blood cells found in the blood of 
the treated rabbits are a normal feature of rabbits 
(Emeribe and Anosa, 1991). These observations suggest 
that Jubi Formula® could have a therapeutic role in cases 
of anemia.  
Consistent with previous reports (Emeribe and Anosa, 
1991) is the development of microcytic hypochromic 
anaemia observed in the rabbits within five weeks of 
inoculation of the rabbits with the parasite. Polychromasia 
observed in some of the rabbits infected with T. b. brucei 
is also consistent with previous report of anisocytosis, 
poikilocytosis, polychromasia and punctate basophilia 
which may all occur together, in part or not at all in 
infected animals (Maré, 2000). Iron deficiency anaemia 
observed in the infected rabbits has been reported 
previously (Mwangi et al., 1995) and Jubi Formula® 
appeared to have eliminated the presence of polychromia 
in the rabbits with T. b. brucei-induced anaemia as 
polychromia was not observed in those animals treated 
with the preparation.  
T. b. brucei is known to cause fever, reduced food and 
water intake within 4 to 6 days post-inoculation, anaemia, 
fibrinogenemia, hypertriglyceridemia, hyperproteinemia, 
transient alteration in the number of neutrophils and 






























































kidney damage (Amole et al., 1990), weight loss and 
severe illness leading to death if untreated (Luckins, 
2000). The parasites are also known to invade brain, 
eyes and skin causing nervous signs, discharge from the 
eyes and oedematous swellings under the skin.  In this 
study, Jubi Formula® was able to produce useful effects 
in reducing the mortality of the parasite infected rabbits, 
and prolonging the life span of the animals. The 
mechanism by which the herbal preparation produced its 
effect on the elevation of PCV and Hb concentrations in 
the experimental rabbits is yet to be determined. The 
herbal preparation may be producing its effects by 
strengthening the body immune system, invigorating the 
defense mechanism, and reducing parasite load in 
infected animals.  
We conclude that Jubi Formula® can increase the PCV 
and Hb concentrations in anemiac laboratory rabbits.  
The progressive recovery of T. b. brucei infected rabbits 
treated with Jubi Formula® is suggestive of progressive 
reduction of parasitemia in the infected animals and 
restoration of PCV and Hb concentrations. The herbal 
preparation may be useful in the treatment of anaemia as 
claimed and may be a potential substitute for blood 
transfusion. The product needs to be further investigated 
for any toxicity prior to clinical trials to ascertain the full 
potentials of the product in anaemia and other disease 
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